Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron M Allen

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Thoracic Cancer|April 24, 2023
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literatureItamar Averbuch, Roi Tschernichovsky, Oded Icht, et al.
Cancer|June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgeryHale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, et al.
Clinical and Translational Radiation Oncology|December 9, 2025
Pediatric CNS relapse of neuroblastoma treated with upright proton craniospinal irradiationPhilip Blumenfeld, Alexander Pryanichnikov, Zelig Tochner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2012
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committeeAaron M Allen, Todd Pawlicki, Lei Dong, et al.
Head & Neck|November 18, 2006
Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancerAaron M Allen, Mohamed Elshaikh, Francis P Worden, et al.
Radiation Oncology (London, England)|October 21, 2017
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinomaAssaf Moore, Michal Cohen-Naftaly, Anna Tobar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsElizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2023
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 StudyNir Peled, Laila C Roisman, Esther Levison, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Thoracic Cancer|April 24, 2023
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literatureItamar Averbuch, Roi Tschernichovsky, Oded Icht, et al.
Cancer|June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgeryHale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, et al.
Clinical and Translational Radiation Oncology|December 9, 2025
Pediatric CNS relapse of neuroblastoma treated with upright proton craniospinal irradiationPhilip Blumenfeld, Alexander Pryanichnikov, Zelig Tochner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2012
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committeeAaron M Allen, Todd Pawlicki, Lei Dong, et al.
Head & Neck|November 18, 2006
Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancerAaron M Allen, Mohamed Elshaikh, Francis P Worden, et al.
Radiation Oncology (London, England)|October 21, 2017
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinomaAssaf Moore, Michal Cohen-Naftaly, Anna Tobar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsElizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2023
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 StudyNir Peled, Laila C Roisman, Esther Levison, et al.
Pageof 8